Trial
NCT00895557
Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Varenicline and the Blunting of Cocaine Cues
Intervention
chantix
Why stopped
This study never started, no funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-08